SCHEMBL22013573

SCHEMBL22013573

Nc1nc2ccc(Br)cc2c2nc(-c3ccco3)nn12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1A1 P48729 3/20 1.00
CSNK1D P48730 3/20 1.00
CSNK1E P49674 2/20 1.00
ADORA3 P0DMS8 10/20 0.74
ADORA2A P29274 10/20 0.74
ADORA1 P30542 9/20 0.74
ADORA2B P29275 8/20 0.74
KDM4E B2RXH2 1/20 0.74
PIK3CD O00329 1/20 0.74
GMNN O75496 1/20 0.74
LMNA P02545 1/20 0.74
CYP1A2 P05177 1/20 0.74
CYP3A4 P08684 1/20 0.74
CYP2D6 P10635 1/20 0.74
MAPT P10636 1/20 0.74
CYP2C9 P11712 1/20 0.74
MAPK1 P28482 1/20 0.74
THPO P40225 1/20 0.74
PIK3CA P42336 1/20 0.74
PIK3CB P42338 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cgs-15943 SCHEMBL29372704 0.85 ADORA3 (1.00) CSNK1A1CSNK1DCSNK1EADORA3ADORA2A
SCHEMBL22013575 0.85 ADORA3 (0.74) CSNK1A1CSNK1DCSNK1EADORA3ADORA2A
Cgs-15943 SCHEMBL1906971 0.85 ADORA3 (1.00) CSNK1A1CSNK1DCSNK1EADORA3ADORA2A
SCHEMBL24209870 0.83 ADORA3 (0.71) CSNK1A1CSNK1DCSNK1EADORA3ADORA2A
SCHEMBL22013580 0.82 ADORA2A (0.70) CSNK1A1CSNK1DCSNK1EADORA3ADORA2A
SCHEMBL22013571 0.82 ADORA3 (0.70) CSNK1A1CSNK1DCSNK1EADORA3ADORA2A
SCHEMBL22013611 0.82 ADORA3 (0.70) CSNK1A1CSNK1DCSNK1EADORA3ADORA2A
SCHEMBL8281286 0.79 ADORA3 (0.65) CSNK1A1CSNK1DCSNK1EADORA3ADORA2A
SCHEMBL22013574 0.78 ADORA3 (0.82) CSNK1A1CSNK1DCSNK1EADORA3ADORA2A
SCHEMBL24210275 0.77 ADORA3 (0.63) CSNK1A1CSNK1DCSNK1EADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102506-A1 ARYL HYDROCARBON RECEPTOR (AHR) ACTIVATOR COMPOUNDS AS CANCER THERAPEUTICS THE BROAD INSTITUTE, INC. (US) 2020-05-22 WO disclosed